Effect of Exercise on MiR-126 in Individuals With Prediabetes
NCT ID: NCT06809257
Last Updated: 2025-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2021-05-01
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus
NCT03682445
Effects of Exercise and Metformin on Methylglyoxal Levels in Prediabetic Individuals
NCT06603480
Effects of Exercise Prediabetic Individuals
NCT06831266
Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients with Prediabetes
NCT06633575
Exercise Dose-Response Effects in Prediabetes
NCT00962962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Individuals in the intervention group were included in a planned aerobic exercise program for 12 weeks.This program was carried out under the supervision of specialist doctors, with the help of sports trainers and physiotherapists, and participants were given 60 minutes of moderate-intensity (50-70% of their maximum heart rate) aerobic exercise three days a week.
Exercise
12 week moderately aerobik exercise
Control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
12 week moderately aerobik exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between the ages of 18-60
* were physically inactive (Level 1 according to the International Physical Activity Questionnaire)
* were motivated to exercise
* Individuals who had no obstacle to exercise as a result of the evaluation made by a cardiologist (ECG, exercise ECG test, etc.)
* and who did not show a change in body weight of more than ±2.5 kg in the last six months were included in the study.
Exclusion Criteria
* current cardiovascular disease, BMI \<19 kg/m²
* history of metformin use within the last 6 months
* receiving hormone replacement therapy
* life expectancy less than one year
* HIV positivity
* substance use
* or orthopedic and cognitive disorders that may prevent exercise
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Yıldırım Ayaz
Assoc. Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif Yıldırım Ayaz
Role: PRINCIPAL_INVESTIGATOR
Sultan 2. Abdülhamid Han Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sultan 2. Abdülhamid Han Training and Research Hospital
Üsküdar, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Saglik Bilimleri University
Identifier Type: OTHER
Identifier Source: secondary_id
EMiR-126-PD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.